NDC 0517-4605 – Glycopyrrolate
Glycopyrrolate .2 mg/mL · Injection, Solution · Intramuscular, Intravenous
Product NDC0517-4605
Product details
- Brand name
- Glycopyrrolate
- Generic name
- Glycopyrrolate
- Labeler
- American Regent, Inc.
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA089335
- Marketed since
- September 30, 1990
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Active ingredients
- Glycopyrrolate .2 mg/mL
Uses, dosage, side effects and warnings for Glycopyrrolate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0517-4605-25 | 25 VIAL, MULTI-DOSE in 1 TRAY (0517-4605-25) / 5 mL in 1 VIAL, MULTI-DOSE (0517-4605-01) | Sep 30, 1990 |
Other Glycopyrrolate products
- 0517-4620 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4602 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4601 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 70121-1698 Glycopyrrolate .2 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70121-1699 Glycopyrrolate .2 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 55150-293 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-295 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-294 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-292 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 72572-226 Glycopyrrolate .2 mg/mL · Injection, Solution · Civica, Inc.
- 65219-801 Glycopyrrolate .2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-578 Glycopyrrolate .2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC